Filing Details
- Accession Number:
- 0001140361-14-009240
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-24 15:56:31
- Reporting Period:
- 2014-02-20
- Filing Date:
- 2014-02-24
- Accepted Time:
- 2014-02-24 15:56:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1094176 | Anne M Szostak | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-20 | 2,000 | $126.71 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $126.65 to $126.83, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
